 This is a superiority trial evaluating statistical superiority. With the 50 five year survival according to national registry for colon cancer, expecting 10 improvement in survival with D3 lymph node dissection, enrollment of 768 patients during 3 year accrual period followed by 5 year follow up is required for a power of 80. 